Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Ticagrelor API

Product
  • Therapeutic Category 心臓血管

  • CAS Number

    274693-27-5

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, EUDMF, Canada DMF, Korea DMF, Russia DMF, China DMF

Mechanism of Action

Ticagrelor and its major metabolite reversibly interact with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent.

Indication

BRILINTA is a P2Y12 platelet inhibitor indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI). For at least the first 12 months following ACS, it is superior to clopidogrel. BRILINTA also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS.

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

フォンダパリヌクスナトリウム

心臓血管

arrow

アムロジピンベシル酸塩

心臓血管

arrow

アピキサバン

心臓血管

arrow

ベムペド酸

心臓血管

arrow

クロピドグレル硫酸水素塩(I型)

心臓血管

arrow

クロピドグレル硫酸水素塩(II型)

心臓血管

arrow

ドキサゾシンメシル酸塩

心臓血管

arrow

エナラプリルマレイン酸塩

心臓血管

arrow

エゼチミブ

心臓血管

arrow

ラシジピン

心臓血管

arrow

コハク酸メトプロロール

心臓血管

arrow

ラミプリル

心臓血管

arrow

リバロキサバン

心臓血管

arrow

チカグレロル

心臓血管

arrow

ロサルタンカリウム

心臓血管

arrow

サクビトリル・バルサルタン

心臓血管

arrow

アトルバスタチンカルシウム(非晶質およびP型)

心臓血管

arrow

アトルバスタチンカルシウム(I型)

心臓血管

arrow

ダビガトランエテキシラートメシル 酸塩

心臓血管

arrow

マバカムテン

心臓血管

arrow

トレプロスチニル

心臓血管

arrow

バルサルタン

心臓血管

arrow

タファミディス

心臓血管

arrow

エドキサバン

心臓血管

arrow

免責事項

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.